Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v2-EN
Language English English
Date Updated 2019-03-29 2018-02-07
Drug Identification Number 02285150 02285150
Brand name TOBRAMYCIN FOR INJECTION U.S.P. TOBRAMYCIN FOR INJECTION U.S.P.
Common or Proper name TOBRAMYCIN FOR INJECTION U.S.P. TOBRAMYCIN FOR INJECTION U.S.P.
Company Name STERIMAX INC STERIMAX INC
Ingredients TOBRAMYCIN TOBRAMYCIN
Strength(s) 1.2G 1.2G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 6 VIALS 6 VIALS
ATC code J01GB J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-02-05 2018-02-05
Estimated end date 2019-01-15 2018-03-15
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Manufacturer changes
Health Canada comments